Metagenomi Therapeutics, Inc. (MGX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2023: $149.67M2024: $89.74M2025: $62.51M$62.51M
2023Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$62.51M-30.3%
2024$89.74M-40.0%
2023$149.67M